BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 19631583)

  • 1. Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigen.
    Kantelhardt VC; Schwarz A; Wend U; Schüttler CG; Willems WR; Trimoulet P; Fleury H; Gerlich WH; Kann M
    J Clin Virol; 2009 Oct; 46(2):124-8. PubMed ID: 19631583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.
    Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L
    Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
    J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of specific IgA and IgM anti-HBc antibodies compared with HBV DNA in the sera of HBsAg chronic carriers.
    Elsana S; Shemer-Avni Y; Sikuler E; Sarov B; Naggan L; Bar-Shany S; Gilon E; Yaari A; Orgel M; Frazer GM; Margalith M
    J Hum Virol; 1997; 1(1):52-7. PubMed ID: 10195231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated core antibody hepatitis B in sub-Saharan African immigrants.
    Gibney KB; Torresi J; Lemoh C; Biggs BA
    J Med Virol; 2008 Sep; 80(9):1565-9. PubMed ID: 18649341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Virological, serological and clinical characteristics of anti-HBc IgM positive chronic hepatitis B patients].
    Zhang CZ; Tian ZX; Shi SZ; Li MH; Xie Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):138-40. PubMed ID: 17653316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
    Landrum ML; Roediger MP; Fieberg AM; Weintrob AC; Okulicz JF; Crum-Cianflone NF; Ganesan A; Lalani T; Macalino GE; Chun HM
    J Med Virol; 2011 Sep; 83(9):1537-43. PubMed ID: 21739443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological detection of hepatitis B viral infection by a panel of solid-phase enzyme-linked immunosorbent assays (ELISA).
    Tsitsilonis OE; Thrasyvoulides A; Balafas A; Voutsas JF; Papamichail M; Lymberi P
    J Pharm Biomed Anal; 2004 Mar; 34(4):811-22. PubMed ID: 15019059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibodies to hepatitis B core antigen using the Abbott ARCHITECT anti-HBc assay: analysis of borderline reactive sera.
    Ollier L; Laffont C; Kechkekian A; Doglio A; Giordanengo V
    J Virol Methods; 2008 Dec; 154(1-2):206-9. PubMed ID: 18848582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc-positive patient after allogeneic stem cell transplantation.
    Gärtner BC; Jung W; Welsch C; Fischinger J; Schubert J; Zeuzem S; Mueller-Lantzsch N; Wend UC; Gerlich WH
    J Clin Virol; 2007 Feb; 38(2):146-8. PubMed ID: 17182277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess HBcAg in HBc antibody-negative chronic hepatitis B virus carriers.
    Lazizi Y; Dubreuil P; Pillot J
    Hepatology; 1993 Jun; 17(6):966-70. PubMed ID: 8514269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening?
    Hourfar MK; Walch LA; Geusendam G; Dengler T; Janetzko K; Gubbe K; Frank K; Karl A; Löhr M; Sireis W; Seifried E; Schmidt M
    Int J Lab Hematol; 2009 Dec; 31(6):649-56. PubMed ID: 18673399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
    Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK
    Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
    Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
    Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay.
    O'Brien SF; Yi QL; Fan W; Fearon MA; Scalia V; Goldman M
    Transfusion; 2009 Feb; 49(2):271-7. PubMed ID: 19389210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.